Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update

Pharmacogenomics. 2020 Jan;21(1):3-6. doi: 10.2217/pgs-2019-0154.
No abstract available

Keywords: DMARD; biomarkers; genetics; methotrexate; pharmacogenetics; precision medicine; rheumatoid arthritis; treatment response.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / genetics
  • Biomarkers / metabolism
  • Humans
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Pharmacogenetics*
  • Precision Medicine

Substances

  • Antirheumatic Agents
  • Biomarkers
  • Methotrexate